We do not publish a verdict for Accendra Health Inc (ACH) and Henry Schein Inc (HSIC) is overvalued.
We publish an intrinsic value for HSIC but not for ACH, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
We do not publish a value for this company: its projected cash flows are negative in every year, including the terminal one.
Leak Score 0/100 on 1 of 12 signals
Discounting its cash flows at 8.0% (average of 3 methods) values the shares at $58.94; the price of $87.43 is 48% above that value, and 79% of that value comes from beyond year five.
Leak Score 14/100 on 3 of 12 signals
| Metric | ACH | HSIC |
|---|---|---|
| Verdict | Not valued | Overvalued |
| Price | $0.85 | $87.43 |
| Intrinsic value | — | $58.94 |
| Margin of safety | — | -48% |
| Leak Score | 0/100 (1/12) | 14/100 (3/12) |
| Market cap | $65M | $9.7B |
| Revenue growth, 5 years | -20.1% | 5.4% |
| Operating margin | 1.4% | 6.0% |
| Net margin | -11.4% | 3.0% |
| Return on equity | -198.3% | 12.2% |
| Debt to equity | — | 1.21 |
| P/E | — | 25.5x |
| Forward P/E | 4.7x | 14.6x |
| P/B | — | 3.1x |